CD40LG and COVID-19: Some general limitations of serology studies for COVID-19 include: it is unknown how long protection lasts; protection is unlikely to be durable given short-lived immunity to other coronaviruses; some people with mild/asymptomatic infections never develop antibody responses at all; serology cannot be used in acute diagnosis; combination IgM/IgG assays are of questionable value due to concerns of cross-reactivity of IgM and other coronavirus antibodies [6,82,107,112,113].